切换至 "中华医学电子期刊资源库"
高级检索
中华损伤与修复杂志(电子版)

中华损伤与修复杂志(电子版) ›› 2019, Vol. 14 ›› Issue (01) : 39 -45. doi: 10.3877/cma.j.issn.1673-9450.2019.01.008

所属专题： 文献；

论著

负压封闭引流技术联合高压氧治疗糖尿病足的临床疗效分析
唐才良1, 晁生武1,†(), 李毅1, 梁琰1   
  1. 1. 810001　西宁，青海大学附属医院烧伤整形外科
  • 收稿日期:2018-12-20 出版日期:2019-02-01
  • 通信作者: 晁生武
  • 基金资助:
    青海省科技厅项目(2016-ZJ-732)

Analysis of clinical effects of vacuum sealing drainage combined with hyperbaric oxygen in the treatment of diabetic foot

Cailiang Tang1, Shengwu Chao1,†(), Yi Li1, Yan Liang1   

  1. 1. Department of Burns and Plastic Surgery, Affiliated Hospital of Qinghai University, Xining 810001, China
  • Received:2018-12-20 Published:2019-02-01
  • Corresponding author: Shengwu Chao
  • About author:
    Corresponding author: Chao Shengwu, Email:
全文 ( ) 下载PDF ( ) 导出引用
引用本文：

唐才良, 晁生武, 李毅, 梁琰. 负压封闭引流技术联合高压氧治疗糖尿病足的临床疗效分析[J/OL]. 中华损伤与修复杂志(电子版), 2019, 14(01): 39-45.

Cailiang Tang, Shengwu Chao, Yi Li, Yan Liang. Analysis of clinical effects of vacuum sealing drainage combined with hyperbaric oxygen in the treatment of diabetic foot[J/OL]. Chinese Journal of Injury Repair and Wound Healing(Electronic Edition), 2019, 14(01): 39-45.

目的

评估负压封闭引流技术(VSD)联合高压氧治疗糖尿病足的临床疗效。

方法

选取2016年9月至2018年4月在青海大学附属医院烧伤整形科就诊的60例确诊为糖尿病足患者，按随机数字表法分为实验组30例和对照组30例，其中对照组予以控制饮食、控制血糖、抗感染等常规治疗的基础上以VSD技术对创面进行治疗；实验组在常规治疗的基础上以VSD技术联合高压氧进行治疗。对2组患者治疗7、14 d的综合疗效情况进行比较，观察治疗前及治疗7、14 d 2组患者血气分析、血液流变学各指标的变化，并观察2组患者治疗前及治疗7、14 d创面组织血管内皮生长因子(VEGF)、血小板衍生生长因子(PDGF)水平的变化以及创面面积大小变化。数据比较采用t检验和χ2检验。

结果

治疗7 d，实验组患者治疗总有效率93.3%(28/30)，明显高于对照组80.0%(24/30)，差异有统计学意义(χ2＝7.231，P<0.05)；治疗7 d，实验组患者血液中酸碱度(7.42±0.19)、PCO2(41.76±1.65) mmHg、血氧分压(66.10±2.36) mmHg、血氧饱和度(89.50±1.62)%、血氧含量(6.60±1.17) Vol%，明显高于对照组[(7.40±0.25)、(40.32±2.70) mmHg、(62.05±5.05) mmHg、(88.10±3.63)%、(6.08±1.17) Vol%]，差异均有统计学意义(t＝2.221、2.442、4.023、2.135、2.073，P值均小于0.05)；治疗7 d，实验组患者全血低切黏度(11.08±0.81) mPa.s、全血高切黏度(5.17±0.34) mPa.s、血浆高切黏度(2.09±0.16) mPa.s、红细胞变形指数(0.76±0.48)，降低情况明显优于对照组[(12.29±1.81) mPa.s、(5.85±0.34) mPa.s、(2.58±0.21) mPa.s、(0.87±0.11)]，差异均有统计学意义(t＝3.265、7.531、10.366、4.942，P值均小于0.05)；治疗7 d，实验组患者创面组织VEGF(35.70±4.84) pg/mL、PDGF(36.60±2.98) pg/mL，较对照组[(25.36±3.21) pg/mL、(27.53±2.94) pg/mL]升高更明显，差异均有统计学意义(t＝9.235、11.134，P值均小于0.05)；治疗7 d，实验组患者创面面积(5.13±0.60) cm2，减小程度明显优于对照组(7.03±0.82) cm2，差异有统计学意义(t＝10.594，P＝0.015)。治疗14 d，实验组患者治疗总有效率96.7%(29/30)，明显强于对照组86.7%(26/30)，差异有统计学意义(χ2＝7.157，P＝0.028)；治疗14 d，实验组患者血液中酸碱度(7.42±0.21)、PCO2(42.46±1.57) mmHg、血氧分压(69.26±1.49) mmHg、血氧饱和度(91.05±1.20)%、血氧含量(6.74±0.89) Vol%，高于对照组[(7.40±0.31)、(40.23±2.73) mmHg、(62.41±4.86) mmHg、(88.23±2.17)%、(6.13±1.22) Vol%]，差异均有统计学意义(t＝2.790、3.778、7.455、6.620、2.185，P值均小于0.05)；治疗14 d，实验组患者全血低切黏度(8.10±1.07) mPa.s、全血高切黏度(4.26±0.33) mPa.s、血浆高切黏度(1.64±0.22) mPa.s、红细胞变形指数(0.64±0.04)，降低情况明显优于对照组[(11.74±1.54) mPa.s、(5.82±0.41) mPa.s、(2.53±0.23) mPa.s、(0.83±0.10)]，差异均有统计学意义(t＝9.905、16.609、16.358、9.617，P值均小于0.05)；治疗14 d，实验组患者创面组织VEGF(47.72±3.75) pg/mL、PDGF(49.17±2.48) pg/mL，较对照组[(37.04±2.90) pg/mL、(38.18±2.65) pg/mL]升高更明显，差异均有统计学意义(t＝13.062、17.276，P值均小于0.05)；治疗14 d，实验组患者创面面积(2.88±0.52) cm2，减小程度明显优于对照组(5.07±0.61) cm2，差异有统计学意义(t＝12.332，P＝0.013)。

结论

VSD联合高压氧治疗对于糖尿病足患者的创面愈合有显著疗效，明显优于单纯使用VSD治疗的疗效，其二者结合的功效十分显著。

关键词: 糖尿病足, 高压氧, 血气分析, 负压封闭引流
Objective

To evaluate the clinical efficacy of vacuum sealing drainage (VSD) combined with hyperbaric oxygen in the treatment of diabetic foot.

Methods

From September 2016 to April 2018, 60 patients with diabetic foot diagnosed in the Department of Burns and Plastic Surgery, Affiliated Hospital of Qinghai University were enrolled. According to the random number table method, 30 patients in the experimental group and 30 patients in the control group were included. On the basis of conventional treatments such as blood sugar control and anti-infection, VSD technology was used in control group; the experimental group was treated with VSD technology combined with hyperbaric oxygen on the basis of conventional treatment. The comprehensive curative effect of 2 groups after 7 and 14 days treatment was compared. The changes of blood rheology and blood gas analysis of 2 groups were observed before and after 7 and 14 days treatment. The changes of vascular endothelial growth factor (VEGF) and platelet derived growth factor (PDGF) levels and wound area were observed before and after 7 and 14 days treatment. Data were compared with t test and χ2 test.

Results

After 7 days of treatment, the total effective rate of the experimental group was 93.3%(28/30), which was significantly stronger than that of the control group [80.0%(24/30)]. The difference was statistically significant (χ2=7.231, P<0.05). In the experimental group, after 7 days of treatment, the pH (7.42±0.19), PCO2 (41.76±1.65) mmHg, blood oxygen partial pressure (66.10±2.36) mmHg, blood oxygen saturation (89.50±1.62)%, blood oxygen content (6.60±1.17) Vol%, significantly higher than the control group [(7.40±0.25), (40.32±2.70) mmHg, (62.05±5.05) mmHg, (88.10±3.63)%, (6.08±1.17) Vol%], the differences were statistically significant (t=2.221, 2.442 , 4.023, 2.135, 2.073, with P values below 0.05); 7 days after treatment, the experimental group patients with low whole blood viscosity (11.08 ± 0.81) mPa.s, whole blood high shear viscosity (5.17 ± 0.34) mPa.s, plasma high shear viscosity (2.09±0.16) mPa.s and the red blood cell deformation index (0.76±0.48), which was significantly better than the control group [(12.29±1.81) mPa.s, (5.85±0.34) mPa.s, (2.58± 0.21) mPa.s, (0.87±0.11)], the differences were statistically significant (t=3.265, 7.531, 10.366, 4.942, with P values below 0.05); after 7 days of treatment, in the experimental group, VEGF (35.70±4.84) pg/mL, PDGF (36.60±2.98) pg/mL, which was more obvious than the control group [(25.36±3.21) pg/mL, (27.53±2.94) pg/mL], the differences were statistically significant (t=9.235, 11.134, with P values below 0.05); 7 days after treatment, the wound area of the experimental group was (5.13±0.60) cm2, the degree of reduction was significantly better than the control group (7.03±0.82) cm2, the difference was statistically significant (t=10.594, P=0.015). After 14 days of treatment, the total effective rate of the experimental group was 96.7%(29/30), which was significantly stronger than that of the control group [86.7%(26/30)], the difference was statistically significant (χ2=7.157, P=0.028). In the experimental group, after 14 days treatment, the pH (7.42± 0.21), partial pressure of carbon dioxide (PCO2) (42.46±1.57) mmHg, blood oxygen partial pressure (69.26±1.49) mmHg, blood oxygen saturation (91.05±1.20)%, blood oxygen content (6.74±0.89) Vol%, significantly higher than the control group [(7.40±0.31), (40.23±2.73) mmHg, (62.41±4.86) mmHg, (88.23±2.17)%, (6.13±1.22) Vol%], the differences were statistically significant (t=2.790, 3.778, 7.455, 6.620, 2.185, with P values below 0.05); after 14 days of treatment, the experimental group had low whole blood viscosity (8.10±1.07) mPa.s, whole blood high shear viscosity (4.26±0.33) mPa.s, plasma high shear viscosity (1.64±0.22) mPa.s, the deformation index of red blood cells (0.64±0.04), which was significantly better than that of the control group [(11.74±1.54) mPa.s, (5.82±0.41) mPa.s, (2.53±0.23) mPa.s, (0.83±0.10)], the differences were statistically significant (t=9.905, 16.609, 16.358, 9.617, with P values below 0.05). In the experimental group, after 14 days treatment, VEGF level was (47.72±3.75) pg/mL and PDGF level was (49.17±2.48) pg/mL, compared with the control group [(37.04±2.90) pg/mL, (38.18±2.65) pg/mL], the difference was statistically significant (t=13.062, 17.276, with P values below 0.05). The wound area of the experimental group after 14 days treatment was (2.88±0.52) cm2, which was significantly better than that of the control group (5.07±0.61) cm2. The difference was statistically significant (t=12.332, P=0.013).

Conclusions

VSD combined with hyperbaric oxygen therapy has a significant effect on the healing of diabetic foot patients, which is significantly better than the efficacy of VSD alone. The combined effect of the two is very significant.

Key words: Diabetic foot, Hyperbaric oxygenation, Blood gas analysis, Vacuum sealing drainage
表1 2组糖尿病足患者一般资料比较(±s)
组别 例数 性别(例) 年龄(岁) 糖尿病病程(年) 空腹血糖(mmol/L) 溃疡面积(cm2) 溃疡时间(d)
男 女
实验组 30 13 17 62.70±5.82 13.74±2.08 11.32±1.80 11.33±0.62 14.04±2.10
对照组 30 15 15 62.13±6.00 13.89±2.06 11.22±1.87 11.03±0.81 13.97±1.94
t值 ? ? ? 0.405 0.260 0.205 1.680 0.113
P值 ? ? ? 0.689 0.797 0.839 0.104 0.911
表2 2组糖尿病足患者综合疗效比较[例(%)]
组别 例数 治疗7 d 治疗14 d
显效 有效 无效 总有效率 显效 有效 无效 总有效率
实验组 30 18(60.0) 10(33.3) 2(6.7) 28(93.3) 23(76.7) 6(20.0) 1(3.3) 29(96.7)
对照组 30 8(26.7) 16(53.3) 6(20.0) 24(80.0) 13(43.3) 13(43.3) 4(13.3) 26(86.7)
χ2值 ? ? ? ? 7.231 ? ? ? 7.157
P值 ? ? ? ? <0.05 ? ? ? 0.028
表3 2组糖尿病足患者治疗前后血气分析(±s)
组别 例数 酸碱度 PCO2(mmHg) 血氧分压(mmHg)
治疗前 治疗7 d 治疗14 d 治疗前 治疗7 d 治疗14 d 治疗前 治疗7 d 治疗14 d
实验组 30 7.41±0.28 7.42±0.19 7.42±0.21 40.76±2.55 41.76±1.65 42.46±1.57 62.78±3.32 66.10±2.36 69.26±1.49
对照组 30 7.40±0.29 7.40±0.25 7.40±0.31 39.85±2.08 40.32±2.70 40.23±2.73 62.22±5.21 62.05±5.05 62.41±4.86
t值 ? 0.449 2.221 2.790 1.607 2.442 3.778 0.500 4.023 7.455
P值 ? 0.657 0.034 0.009 0.119 0.021 0.001 0.621 0.030 0.021
组别 例数 血氧饱和度(%) 血氧含量(Vol%)
治疗前 治疗7 d 治疗14 d 治疗前 治疗7 d 治疗14 d
实验组 30 88.45±1.76 89.50±1.62 91.05±1.20 6.31±0.93 6.60±1.17 6.74±0.89
对照组 30 87.56±3.29 88.10±3.63 88.23±2.17 6.15±1.23 6.08±1.17 6.13±1.22
t值 ? 1.254 2.135 6.620 0.587 2.073 2.185
P值 ? 0.220 0.041 0.011 0.565 0.047 0.037
表4 2组糖尿病足患者治疗前后血液流变学参数(±s)
组别 例数 全血低切黏度(mPa.s) 全血高切黏度(mPa.s)
治疗前 治疗7 d 治疗14 d 治疗前 治疗7 d 治疗14 d
实验组 30 12.74±1.07 11.08±0.81 8.10±1.07 5.89±0.36 5.17±0.34 4.26±0.33
对照组 30 12.85±1.14 12.29±1.81 11.74±1.54 5.97±0.32 5.85±0.34 5.82±0.41
t值 ? 0.378 3.265 9.905 1.414 7.531 16.609
P值 ? 0.709 0.015 0.008 0.168 0.009 0.004
组别 例数 血浆高切黏度(mPa.s) 红细胞变形指数
治疗前 治疗7 d 治疗14 d 治疗前 治疗7 d 治疗14 d
实验组 30 2.61±0.60 2.09±0.16 1.64±0.22 0.89±0.76 0.76±0.48 0.64±0.04
对照组 30 2.62±0.18 2.58±0.21 2.53±0.23 0.90±0.85 0.87±0.11 0.83±0.10
t值 ? 0.101 10.366 16.358 1.292 4.942 9.617
P值 ? 0.918 0.007 0.004 0.206 0.011 0.008
表5 2组糖尿病足患者治疗前后组织VEGF、PDGF水平变化(pg/mL, ±s)
组别 例数 VEGF PDGF
治疗前 治疗7 d 治疗14 d 治疗前 治疗7 d 治疗14 d
实验组 30 2.13±0.41 35.70±4.84 47.72±3.75 2.08±0.28 36.60±2.98 49.17±2.48
对照组 30 2.12±0.43 25.36±3.21 37.04±2.90 2.12±0.26 27.53±2.94 38.18±2.65
t值 ? 0.205 9.235 13.062 0.539 11.134 17.276
P值 ? 0.839 0.012 0.009 0.594 0.013 0.008
[1]
Apelqvist J, Bakker K, van Houtum WH, et al. International consensus and practical guidelines on the management and the prevention of the diabetic foot.lnternational Working Group on the Diabetic Foot[J]. Diabetes Metab Res Rev, 2000, 16 Suppl 1: 84-92.
[2]
Basha B, Samuel SM, Triggle CR, et al. Endothelial dysfunction in diabetes mellitus: possible involvement of endoplasmic reticulum stress？[J]. Exp Diabetes Res, 2012, 2012: 481840.
[3]
Schneider AM, Morykwas MJ, Argenta LC, et al. A new and reliable method of securing skin grafts to the difficult recipient bed[J]. Plast Reconstr Surg, 1998, 102(4): 1195-1198.
[4]
张旭艳, 王中京, 丁胜, 等. 封闭负压引流治疗糖尿病足溃疡的疗效及对VEGF、MMP-2及TIMP-1的影响[J]. 中国老年学杂志, 2018, 38(6): 1289-1291.
[5]
胡承诺, 李东宇, 庞宗超, 等. 封闭式负压引流技术治疗糖尿病足对创面组织中TGF-β1及其受体表达的影响研究[J]. 中国修复重建外科杂志, 2018, 32(8): 1061-1065.
[6]
吴汉妮, 孙晖. 高压氧治疗糖尿病足的临床疗效[J]. 中华物理医学与康复杂志, 2003, 25(6): 371-373.
[7]
Yuan J, Handy RD, Moody AJ, et al. Response of blood vessels in vitro to hyperbaric oxygen (HBO): modulation of VEGF and NO(x) release by external lactate or arginine[J]. Biochim Biophys Acta, 2009, 1787(7): 828-834.
[8]
Hopf HW, Gibson JJ, Angeles AP, et al. Hyperoxia and angiogenesis[J]. Wound Repair Regen, 2005, 13(6): 558-564.
[9]
Alberti KG, Zimmet PZ. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation[J]. Diabet Med, 1998, 15(7): 539-553.
[10]
Wagner FW Jr. The dysvascular foot: a system for diagnosis and treatment[J]. Foot Ankle, 1981, 2(2): 64-122.
[11]
吴钟琪. 高压氧临床医学[M]. 长沙：中南大学出版社, 2003: 192-193, 230-231.
[12]
Mauricio D, Jude E, Piaggesi A, et al. Diabetic foot: current status and future prospects[J]. J Diabetes Res, 2016, 2016: 5691305.
[13]
Leone S, Pascale R, Vitale M, et al. Epidemiology of diabetic foot[J]. Infez Med, 2012, 20 Suppl: 8-13.
[14]
Bortoletto MS, de Andrade SM, Matsuo T, et al. Risk factors for foot ulcers-A cross sectional survey from a primary care setting in Brazil[J]. Prim Care Diabetes, 2014, 8(1): 71-76.
[15]
Waaijman R, de Haart M, Arts ML, et al. Risk factors for plantar foot ulcer recurrence in neuropathic diabetic patients[J]. Diabetes Care, 2014, 37(6): 1697-1705.
[16]
Monteiro-Soares M, Boyko EJ, Ribeiro J, et al. Predictive factors for diabetic foot ulceration: a systematic review[J]. Diabetes metab Res Rev, 2012, 28(7): 574-600.
[17]
Moues CM, Heule F, Hovius SE. A review of topical negative pressure therapy in wound healing: sufficient evidence？[J]. Am J Surg, 2011, 201(4): 544-556.
[18]
Kamoh LP, Andel H, Haslik W, et al. Use of subatmospherie pressure therapy to prevent burn wound progression in human: first experiences[J]. Burns, 2004, 30(3): 253-258.
[19]
Seherer SS, Pietramaggiori G, Mathews JC, et al. The meeha-nism of action of the vacuum-assisted closure devicer[J]. Plast Reconstr Surg, 2008, 122(3): 786-797.
[20]
Fabian TS, Kaufman HJ, Lett ED, et al. The evaluation of sub. atmospheric pressure and hyperbaric oxygen in ischemic fullthickness wound healing[J]. Am Surg, 2000, 66(12): 1136-1143.
[21]
Labler L, Rancan M, Mica L, et al. Vacuum-assisted closure therapy increases local interleukin-8 and vascular endothelial growth factor levels in traumatic wounds[J]. J Trauma, 2009, 66(3): 749-757.
[22]
Meara GJ, Guo L, Smith JD, et al. Vacuum Assisted Closure in the treatment of degloving injuries[J]. Am Plast Surg, 1999, 42(6): 589-594.
[23]
Shon YS, Lee YN, Jeong SH, et al. Influence of negative-pressure wound therapy on tissue oxygenation of the foot[J]. Arch Plast Surg, 2014, 41(6): 668-672.
[24]
Barata P, Cervaens M, Resende R, et al. Hyperbaric oxygen effects on sports injuries[J]. Ther Adv Musculoskelet Dis, 2011, 3(2): 111-121.
[25]
曾宪忠, 刘氜, 李毅. 高压氧治疗糖尿病足的疗效评价及对患者血清VEGF、bFGF水平的影响[J]. 中国现代医学杂志, 2016, 26(19): 110-113.
[1] 朱颖军, 张敏, 王加玉. 小剂量去甲肾上腺素对蛛网膜下腔-硬膜外联合麻醉剖宫产术分娩新生儿影响[J/OL]. 中华妇幼临床医学杂志(电子版), 2023, 19(06): 728-733.
[2] 王杰, 袁泉, 王玥琦, 乔佳君, 谭春丽, 夏仲元, 刘守尧. 溃疡油在糖尿病足溃疡治疗中的应用效果及安全性观察[J/OL]. 中华损伤与修复杂志(电子版), 2024, 19(06): 480-484.
[3] 姜珊, 李湘燕, 田硕涵, 温冰, 何睿, 齐心. 采用优化抗感染治疗模式改善糖尿病足感染预后的临床观察[J/OL]. 中华损伤与修复杂志(电子版), 2024, 19(05): 398-403.
[4] 别瑶, 曹志斌, 辛静, 王健楠, 惠宗光. 应用基质血管成分细胞治疗糖尿病足溃疡的研究进展[J/OL]. 中华损伤与修复杂志(电子版), 2024, 19(05): 453-456.
[5] 谢芬, 陈洁, 张媛媛, 刘茜, 胡芬, 李恭驰, 李炳辉, 金环. 移动健康管理模式在糖尿病足管理中的应用效果观察[J/OL]. 中华损伤与修复杂志(电子版), 2024, 19(04): 335-340.
[6] 苏永涛, 王春雷, 徐广琪, 关中正, 焦伟, 隋颖. 胫骨骨膜牵张术联合富血小板血浆对治疗糖尿病足溃疡的疗效观察[J/OL]. 中华损伤与修复杂志(电子版), 2024, 19(03): 238-244.
[7] 杨丽, 李文颖, 田园, 周林熙, 王伟. 脂质水胶体硫酸银敷料和蔗糖八硫酸盐敷料在糖尿病足溃疡中的应用进展[J/OL]. 中华损伤与修复杂志(电子版), 2024, 19(03): 271-275.
[8] 孙艺玮, 陈炜, 秦巍, 杜景辰, 孟昕, 周永军. 血管腔内介入治疗糖尿病足合并下肢动脉硬化闭塞症患者术后再狭窄与血清炎症因子的相关性[J/OL]. 中华损伤与修复杂志(电子版), 2024, 19(01): 34-40.
[9] 廖晓霜, 曾李, 杨波. 脱细胞同种异体真皮联合自体皮修复糖尿病足创面的临床效果[J/OL]. 中华损伤与修复杂志(电子版), 2024, 19(01): 46-50.
[10] 阙宏亮, 邓君鹏, 李权, 曾腾跃, 沈华, 谢建军. 俯卧位经后腹腔肾上腺腹腔镜手术的研究进展[J/OL]. 中华腔镜泌尿外科杂志(电子版), 2024, 18(02): 188-192.
[11] 胡贤瑞, 伍振国, 何竟. 高压氧治疗创伤性脑损伤患者认知功能障碍疗效的Meta分析[J/OL]. 中华脑科疾病与康复杂志(电子版), 2024, 14(01): 21-36.
[12] 邸志娟, 李红玲. HBOT在创伤性脑损伤患者中的应用及研究进展[J/OL]. 中华脑科疾病与康复杂志(电子版), 2023, 13(06): 373-378.
[13] 李瑞琦, 吴子健, 吴杰斌, 任佳佳, 翟敬芳. 动脉血气分析判读Excel电子表格在实习生酸碱平衡紊乱教学中的应用[J/OL]. 中华临床医师杂志(电子版), 2023, 17(06): 737-743.
[14] 黄晨, 庄炜钊, 刘合祝, 李永生, 王倩, 唐郁宽. 富血小板凝胶联合腔内血管成形术治疗缺血性糖尿病足的研究[J/OL]. 中华介入放射学电子杂志, 2024, 12(01): 27-32.
[15] 田桦, 丁芳, 黄晓莉, 张丽君. 脑蛋白水解物对痉挛型脑瘫患儿肌肉痉挛评分、脑血流量及血清IGF-1、MBP、IL-6的影响[J/OL]. 中华脑血管病杂志(电子版), 2024, 18(01): 49-54.
阅读次数
全文


摘要

版权所有 中华医学会 中华医学电子音像出版社有限责任公司  京ICP备14006079号-1  网络出版服务许可证：(署)网出证(京)字第075号